SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Tunica Albuginea who wrote (5036)1/27/1998 9:51:00 AM
From: Mkilloran  Read Replies (2) | Respond to of 23519
 
vvus ......on the rise
The adv PE for this group is 27. 1997 earnings $1 with analyst adv
for 1998 at $1.56 1999 at $2,85
VVUS shot it self in the foot in 4th qtr by moving one production line from the current FDA certified plant to their new plant.
This disappointment in 4th qtr earnings created a great buy in the low teens. However this should prove to be a safe way to insure the new plant moves thru the FDA certification smoothly....proven equiptment and staff. Not to mention a smart move in Dec to hire experienced plant manager from Lilly.
$40 + in 98....Ad's start this week...MCA and FDA approvals this qtr.
.........................................................................................................
MUSE is the proven product PFE will help expand the market later in
98........there's room for both (just like the computer field MSFT SUNW IBM ....etc,etc,etc)
..........................................................................................................
Question...????
If you had a classic car in the garage up on blocks, would you take it
out for a spin if your local mechanic had a product that would bring it back to life...A quick MUSE tuneup and take your lady for a drive
with your DREAM MACHINE......
............................................................................................................